These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11099655)

  • 1. Transfusion to blood group A and O patients of group B RBCs that have been enzymatically converted to group O.
    Kruskall MS; AuBuchon JP; Anthony KY; Herschel L; Pickard C; Biehl R; Horowitz M; Brambilla DJ; Popovsky MA
    Transfusion; 2000 Nov; 40(11):1290-8. PubMed ID: 11099655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple-unit and second transfusions of red cells enzymatically converted from group B to group O: report on the end of phase 1 trials.
    Lenny LL; Hurst R; Zhu A; Goldstein J; Galbraith RA
    Transfusion; 1995; 35(11):899-902. PubMed ID: 8604485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusions to group O subjects of 2 units of red cells enzymatically converted from group B to group O.
    Lenny LL; Hurst R; Goldstein J; Galbraith RA
    Transfusion; 1994 Mar; 34(3):209-14. PubMed ID: 8146892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal red blood cells--enzymatic conversion of blood group A and B antigens.
    Olsson ML; Hill CA; de la Vega H; Liu QP; Stroud MR; Valdinocci J; Moon S; Clausen H; Kruskall MS
    Transfus Clin Biol; 2004 Feb; 11(1):33-9. PubMed ID: 14980547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-unit transfusions of RBC enzymatically converted from group B to group O to A and O normal volunteers.
    Lenny LL; Hurst R; Goldstein J; Benjamin LJ; Jones RL
    Blood; 1991 Mar; 77(6):1383-8. PubMed ID: 1848117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modifying the red cell surface: towards an ABO-universal blood supply.
    Olsson ML; Clausen H
    Br J Haematol; 2008 Jan; 140(1):3-12. PubMed ID: 17970801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulating the red cell membrane to produce universal/stealth donor red cells suitable for transfusion.
    Garratty G
    Vox Sang; 2008 Feb; 94(2):87-95. PubMed ID: 18034787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically engineered pig red blood cells for clinical transfusion: initial in vitro studies.
    Long C; Hara H; Pawlikowski Z; Koike N; d'Arville T; Yeh P; Ezzelarab M; Ayares D; Yazer M; Cooper DK
    Transfusion; 2009 Nov; 49(11):2418-29. PubMed ID: 19624491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward universal donor blood: Enzymatic conversion of A and B to O type.
    Rahfeld P; Withers SG
    J Biol Chem; 2020 Jan; 295(2):325-334. PubMed ID: 31792054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusion of ABO-group identical red blood cells following uncrossmatched transfusion does not lead to higher mortality in civilian trauma patients.
    Yazer MH; Dunbar NM; Hess JR; Tuott EE; Bahmanyar M; Campbell J; Fontaine M; Ko A; Mi J; Murphy MF; Poisson J; Raval JS; Shih AW; Sperry JL; Staves J; Wong M; Yan MTS; Ziman A; Seheult JN
    Transfusion; 2023 May; 63 Suppl 3():S46-S53. PubMed ID: 36971017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group O RBCs: where is universal donor blood being used.
    Barty RL; Pai M; Liu Y; Arnold DM; Cook RJ; Zeller MP; Heddle NM
    Vox Sang; 2017 May; 112(4):336-342. PubMed ID: 28321880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research advance on universal red blood cell engineering].
    Tan YX; Ji SP; Gong F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):814-9. PubMed ID: 21729578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of outcomes of group O vs non-group O premature neonates receiving group O RBC transfusions.
    Boral LI; Staubach ZG; de Leeuw R; Macivor DC; Kryscio R; Bada HS
    Am J Clin Pathol; 2013 Dec; 140(6):780-6. PubMed ID: 24225743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of group A1B erythrocytes converted to type as group O: studies of markers of function and compatibility.
    Gao HW; Zhuo HL; Zhang X; Ji SP; Tan YX; Li SB; Jia YJ; Xu H; Wu QF; Yun ZM; Luo Q; Gong F
    Blood Transfus; 2016 Mar; 14(2):168-74. PubMed ID: 26509826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute intravascular hemolysis after transfusion of a chimeric RBC unit.
    Pruss A; Heymann GA; Hell A; Kalus UJ; Krausch D; Dörner T; Kiesewetter HH; Salama A
    Transfusion; 2003 Oct; 43(10):1449-51. PubMed ID: 14507278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe hemolytic anemia due to multiple red cell alloantibodies after an ABO-incompatible allogeneic bone marrow transplant.
    López A; de la Rubia J; Arriaga F; Jiménez C; Sanz GF; Carpio N; Marty ML
    Transfusion; 1998 Mar; 38(3):247-51. PubMed ID: 9563404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of haemolysis markers following transfusion of uncrossmatched, low-titre, group O+ whole blood in civilian trauma patients: initial experience at a level 1 trauma centre.
    Seheult JN; Triulzi DJ; Alarcon LH; Sperry JL; Murdock A; Yazer MH
    Transfus Med; 2017 Feb; 27(1):30-35. PubMed ID: 27730689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety of ABO minor incompatible platelets transfusions using a rapid infuser.
    Jung Y; Luo O; Sen N; Li FM; Hasan RA; Hess AS; Hess JR; Sabath DE; Tsang HC; Pagano MB
    Transfusion; 2024 Mar; 64(3):449-453. PubMed ID: 38299721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O- product transfusion, inventory management, and utilization during shortage: the OPTIMUS study.
    Dunbar NM; Yazer MH;
    Transfusion; 2018 Jun; 58(6):1348-1355. PubMed ID: 29479703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in modulating the RBC membrane to produce transfusable universal/stealth donor RBCs.
    Garratty G
    Transfus Med Rev; 2004 Oct; 18(4):245-56. PubMed ID: 15497125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.